January 23, 2019 08:46 AM EST
News Briefing

RNAi leader Al­ny­lam inks col­lab­o­ra­tion pact with start­up; GV's Rosana Kapeller joins Schrödinger board

ENDPOINTS

→ Eight months af­ter putting to­geth­er its $30 mil­lion A round, biotech start­up CAMP4 has inked a new col­lab­o­ra­tion with RNAi trend­set­ter Al­ny­lam. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times